Top 3 Quotes & Sayings by Pascal Couchepin

Explore popular quotes and sayings by a Swiss politician Pascal Couchepin.
Last updated on December 3, 2024.
Pascal Couchepin

Pascal Couchepin is a Swiss politician who served as a Member of the Swiss Federal Council from 1998 to 2009. A member of the Free Democratic Party (FDP/PRD), he was President of the Swiss Confederation twice, in 2003 and 2008. Couchepin headed the Federal Department of Economic Affairs from 1998 to 2002 and Federal Department of Home Affairs from 2003 until 2009.

In the Swiss government there is a will to limit the number of doctors themselves, because with new bilateral agreements with the European Union, there is what we call the "free flow of persons"; that our borders are open to immigration. And as the Swiss doctors are better paid than others, we could have a huge increase of immigration of doctors, more than we need. So we decided to limit the numbers of doctors coming into Switzerland. It is not a very intelligent system, but it is the best one that we have found to limit immigration of doctors.
If you look at figures, we have a good supply of doctors in Switzerland. They always say that in the future we shall have a lack of home doctors, family doctors. I'm not sure of that, but we have a problem of formation. Every year there [are] about 1,000 students beginning medical studies, and at the end of the formation there are only 600 young people getting the diploma. It means that about 40 percent of the students fail during the studies, although there is a selection at the beginning. Forty percent is too much as failure, so probably there is a problem in the formation, education.
If you look at the expenses of a great pharmaceutical company, they pay between about 10 to 15 percent of their expenses for research, but they use 30 to 40 percent of their incomes for marketing and promotion. It is not completely wrong that they spend so much, but it is not correct to say that there is a direct connection between the price of drugs and the cost of research. It could be more between the cost of marketing and the cost of the drugs.
This site uses cookies to ensure you get the best experience. More info...
Got it!